Through successful and ongoing research collaborations, Medical Ethics has developed a proven platform technology, which is supported by strong IP protection. Active government support has enabled these collaborations with Sydney, Lisbon (Portugal) and Padua (Italy) Universities, and Australian livestock industries to be funded by Australian, Canadian and EU governments.
Secured a prestigious Australian Research Council Linkage Grant with partners Sydney University and Bayer Animal Health in November 2007. The AUS$2.1m grant allowed us to accelerate our research into practical and effective pain management for livestock undergoing necessary animal surgical procedures.
In July 2015, Tri-Solfen® was identified as the number one registration priority for Australia’s sheep, cattle,
pig and alpaca industries, for use during surgical procedures. The Australian Government Rural Industries and Research Development Corporation (RIRDC) stated that Tri-Solfen® was an urgent priority on its AgVet Technology Priority List.
The Royal Society for the Prevention of Cruelty to Animals (RSPCA) has identified the need for animal surgical procedures to be accompanied by appropriate pain relief products.
Media releases relating to Tri-Solfen® by the RSPCA: